The FDA pulls key DEI initiative for cancer studies from its website A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives. Sydney Lupkin
Talking with the first person to receive a new kind of pig kidney transplant NPR visits first person to get a new kind of genetically modified pig kidney two weeks after undergoing the historic procedure. Rob Stein
Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. Sydney Lupkin
Customized CRISPR treatments could help people with rare genetic disorders The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders. Rob Stein
Surgeries are being canceled after Helene shut down a factory that makes IV fluids When Hurricane Helene took out a factory making 60% of the country's IV fluids, it caused shortages that have led to canceled surgeries. A look at the effects and prospects for improvement. Sydney Lupkin
UW biochemist wins Nobel Prize for using computers to design proteins A biochemist at the University of Washington School of Medicine has won the Nobel Prize in Chemistry for his groundbreaking work in computational protein design. Ann Dornfeld
For the first time in decades, the FDA has approved a new type of schizophrenia drug The FDA has approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage over current treatments is milder side effects. Sydney Lupkin
Very few people are getting the latest COVID-19 vaccines So far, very few people have been rolling up their sleeves to get the latest COVID-19 vaccines according to the first data from the CDC tracking demand for the new shots. Rob Stein
Novo Nordisk CEO is grilled by a Senators about high cost of Ozempic Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans pay for Ozempic and Wegovy compared with people in other countries. Sydney Lupkin
The FTC has filed a lawsuit over the artificially inflation of the price of insulin The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs. Sydney Lupkin